SOX21 suppresses glioblastoma growth by repressing AP-1 activity
Open Access
- 31 January 2026
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Abstract
Treatment-resistant glioblastoma stem and precursor cells (GPCs) drive glioblastoma (GBM) growth and recurrence. Thus, targeting the molecular machinery that sustains GPCs in an undifferentiated and self-renewing state is a promising therapeutic strategy. The transcription factor SOX21 effectively suppresses the tumorigenic capacity of GPCs, but the mechanism by which SOX21 impedes GPC features is unknown. By engineering patient-derived GPCs with a transgenic TetOn system we show that SOX21 expression induces an anti-tumorigenic transcriptional program, aligning with clinical data demonstrating a positive correlation between SOX21 levels and improved GBM patient survival. Induced SOX21 expression in GPCs within pre-established GBM reduces their capacity to sustain tumor growth and significantly extends the survival of the orthotopically transplanted mice. Mechanistically, SOX21 functions as a tumor suppressor by binding a large set of AP-1-targeted chromatin regions, leading to epigenetic repression of AP-1-activated genes. Consistently, the anti-tumorigenic activities of SOX21 are largely replicated by AP-1 inhibitors, which decrease GPC proliferation and survival, while overexpression of the AP-1 family member, c-JUN, counteracts these effects. Our findings identify SOX21 as a key regulator that prevents GPC malignancy by targeting and repressing an AP-1-driven, tumor-promoting gene expression program. These results highlight SOX21-regulated pathways as promising therapeutic targets for GBM.Keywords
All Related Versions
Funding Information
- Cancerfonden (21 1741 Pj 01 H)
- Vetenskapsrådet (2021-03083)
- Barncancerfonden (PR2022-0101)
- Barncancerfonden (PR2022-0101)
- Hjärnfonden (FO2022-0231)
- Hjärnfonden (FO2025-0373)
- Wenner-Gren Foundation (UPD2021-0208)
- Associazione Italiana per la Ricerca sul Cancro (No. 26794)
This publication has 54 references indexed in Scilit:
- Glioblastoma and Other Primary Brain Malignancies in AdultsJAMA, 2023
- Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticityDevelopmental Cell, 2022
- The AP-1 transcriptional complex: Local switch or remote command?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Determinants of Histone H3K4 Methylation PatternsMolecular Cell, 2017
- Inhibition of Pluripotency Networks by the Rb Tumor Suppressor Restricts Reprogramming and TumorigenesisCell Stem Cell, 2015
- Sox21 inhibits glioma progressionin vivoby forming complexes with Sox2 and stimulating aberrant differentiationInternational Journal of Cancer, 2013
- The Sox Family of Transcription Factors: Versatile Regulators of Stem and Progenitor Cell FateCell Stem Cell, 2013
- SOX–partner code for cell specification: Regulatory target selection and underlying molecular mechanismsThe International Journal of Biochemistry & Cell Biology, 2010
- Olig2-Regulated Lineage-Restricted Pathway Controls Replication Competence in Neural Stem Cells and Malignant GliomaNeuron, 2007
- Core Transcriptional Regulatory Circuitry in Human Embryonic Stem CellsCell, 2005